<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Y. Liu-Chittenden | seandavi(s12)</title>
    <link>/authors/y.-liu-chittenden/</link>
      <atom:link href="/authors/y.-liu-chittenden/index.xml" rel="self" type="application/rss+xml" />
    <description>Y. Liu-Chittenden</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Sun, 01 Jan 2017 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_2.png</url>
      <title>Y. Liu-Chittenden</title>
      <link>/authors/y.-liu-chittenden/</link>
    </image>
    
    <item>
      <title>RARRES2 functions as a tumor suppressor by promoting $Î²$-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma</title>
      <link>/publication/pmid-28114280/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      <guid>/publication/pmid-28114280/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer</title>
      <link>/publication/pmid-25944801/</link>
      <pubDate>Tue, 01 Sep 2015 00:00:00 +0000</pubDate>
      <guid>/publication/pmid-25944801/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
